Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Cetuximab 250, Squamous Cell Carcinoma of the Skin, Cycle 2+

Protocol-ID: 2166 V1.0 (Mini), CETU250, CSCC, C2+

Indication(s)

  • Squamous Cell Carcinoma of the Skin; ICD-10 C44.9
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 13.10.2022